This is a Validated Antibody Database (VAD) review about cow RB1, based on 52 published articles (read how Labome selects the articles), using RB1 antibody in all methods. It is aimed to help Labome visitors find the most suited RB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RB1 synonym: P105-RB; PP110; RB11; retinoblastoma-associated protein; retinoblastoma 1 (including osteosarcoma); retinoblastoma, susceptibility

Cell Signaling Technology
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology RB1 antibody (CST, 9309) was used in western blot on human samples (fig 1e). Cell Rep (2019) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 1c). Oncotarget (2018) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; fig 5a
Cell Signaling Technology RB1 antibody (New England Biolab, 9309) was used in western blot on human samples at 1:1000 (fig 5a). Oncogene (2018) ncbi
mouse monoclonal (4H1)
  • other; human; loading ...; fig 4c
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:3000; loading ...; fig 7a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:3000 (fig 7a). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig s3
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000 (fig s3). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 1e). ACS Chem Biol (2018) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 2b). Tumour Biol (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000; loading ...; fig 5j, 5l
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:2000 (fig 5j, 5l). Gut (2018) ncbi
mouse monoclonal (4H1)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology RB1 antibody (CST, 9309) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; fig 5a
In order to determine the contribution of NOX4 to the development of pancreatic ductal adenocarcinoma, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000 (fig 5a). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 5h
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on human samples (fig 5h). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 8a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 8a). J Cell Physiol (2017) ncbi
mouse monoclonal (4H1)
  • western blot; mouse; 1:1000; loading ...; fig S1h
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on mouse samples at 1:1000 (fig S1h). Nat Commun (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 2a
In order to identify pathways that contribute to resistance to the antiandrogen drug enzalutamide, Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples (fig 2a). Science (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples . Cell Syst (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 1c
In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 1c). Oncotarget (2017) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000; loading ...; fig 5a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:2000 (fig 5a). Cell Cycle (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 6e
In order to determine the rotavirus NSP1-host protein interaction network, Cell Signaling Technology RB1 antibody (CST, 4H1) was used in western blot on human samples (fig 6e). PLoS Pathog (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 1d
Cell Signaling Technology RB1 antibody (cell signalling, 9309) was used in western blot on human samples at 1:1000 (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 3
In order to test if interactions between pUL97 and other viral proteins can be detected by mass spectrometry-based approaches, Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 3). Viruses (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 6b
In order to assess the anticancer properties of 3',4',5'-trimethoxy-5-chloro-isatinylchalcone, Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 6b). PLoS ONE (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 3f
In order to elucidate the role of NOTCH1 in oncogene-induced senescence, Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on human samples at 1:1000 (fig 3f). Nat Cell Biol (2016) ncbi
mouse monoclonal (4H1)
  • chromatin immunoprecipitation; human; fig 3
  • western blot; human; fig 2
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in chromatin immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 2). elife (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 6
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 6). Genome Biol (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 3
Cell Signaling Technology RB1 antibody (Cell Signaling Tech, 9309S) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 4c
In order to elucidate how p21 is suppressed in embryonic stem cells, Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 4c). Sci Rep (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000; fig s5
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309P) was used in western blot on human samples at 1:2000 (fig s5). Nat Commun (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 3
In order to study inhibition in hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer cells with acquired resistance to Paclitaxel by effects of CDK4/6, Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples (fig 3). J Cancer (2016) ncbi
mouse monoclonal (4H1)
  • immunoprecipitation; human; fig 1
  • western blot; human; fig 1
In order to analyze enhancement of binding with CDK2 and phosphorylation at early G1 phase by SUMOylationn of Rb, Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in immunoprecipitation on human samples (fig 1) and in western blot on human samples (fig 1). Cell Cycle (2016) ncbi
mouse monoclonal (4H1)
  • western blot; mouse; 1:1000; loading ...; fig s10b
In order to use naked mole-rat-induced pluripotent stem cells to study mechanisms of cancer resistance, Cell Signaling Technology RB1 antibody (CST, 9,309) was used in western blot on mouse samples at 1:1000 (fig s10b). Nat Commun (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 4
In order to study attenuation of AKT signaling to promote internal ribosome entry site-dependent translation and expression of c-MYC by the human papillomavirus 16 E7 oncoprotein, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 4). J Virol (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 5
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig s3e
Cell Signaling Technology RB1 antibody (CST, 9309) was used in western blot on human samples (fig s3e). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig st3
In order to study the DNA damage response in senescent epithelial cells, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000 (fig st3). Nat Commun (2016) ncbi
mouse monoclonal (4H1)
  • western blot; rat; fig 8a
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on rat samples (fig 8a). J Diabetes Res (2016) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 4
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 4). Cell Cycle (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 3d
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 3d). PLoS ONE (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 7
In order to analyze sensitivity to the cyclin D1/CDK4 pathway inhibition in Ewing sarcoma by a chemical genomic, functional, and super-enhancer screening, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 7). Oncotarget (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:500; loading ...; fig 10a
Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples at 1:500 (fig 10a). PLoS ONE (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 2
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 2). Mol Biol Cell (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology RB1 antibody (Cell signaling, 9309) was used in western blot on human samples at 1:1000 (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:2000
In order to study the regulation of the human papillomavirus 16 oncoprotein expression, Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 4H1) was used in western blot on human samples at 1:2000. J Virol (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; loading ...; fig 1
Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples (fig 1). J Virol (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000; loading ...; fig 5g
Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 4H1) was used in western blot on human samples at 1:1000 (fig 5g). Nat Commun (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 4f
In order to study the role of N-terminal acetylation in Ogden syndrome, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 4f). Hum Mol Genet (2015) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 2d
In order to study the effects of cyclin-dependent kinase 7 inhibitors on MYC proteins, Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples (fig 2d). Cell (2014) ncbi
mouse monoclonal (4H1)
  • western blot; human; 1:1000
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309) was used in western blot on human samples at 1:1000. Cell (2014) ncbi
mouse monoclonal (4H1)
  • western blot; human
Cell Signaling Technology RB1 antibody (Cell Signaling, 9309P) was used in western blot on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (4H1)
  • western blot; human
Cell Signaling Technology RB1 antibody (Cell signaling, 4H1) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (4H1)
  • western blot; human; fig 5
Cell Signaling Technology RB1 antibody (Cell Signaling Technology, 9309) was used in western blot on human samples (fig 5). Oncogenesis (2012) ncbi
mouse monoclonal (4H1)
  • western blot; human
Cell Signaling Technology RB1 antibody (Cell Signaling, 4H1) was used in western blot on human samples . Cancer Res (2013) ncbi
Articles Reviewed
  1. Cornell L, Wander S, Visal T, Wagle N, Shapiro G. MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Rep. 2019;26:2667-2680.e7 pubmed publisher
  2. Bernal A, Moltó Abad M, Dominguez D, Tusell L. Acute telomere deprotection prevents ongoing BFB cycles and rampant instability in p16INK4a-deficient epithelial cells. Oncotarget. 2018;9:27151-27170 pubmed publisher
  3. Brough R, Gulati A, Haider S, Kumar R, Campbell J, Knudsen E, et al. Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer. Oncogene. 2018;37:5701-5718 pubmed publisher
  4. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  5. Fang J, Coon B, Gillis N, Chen Z, Qiu J, Chittenden T, et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat Commun. 2017;8:2149 pubmed publisher
  6. Oldrini B, Hsieh W, Erdjument Bromage H, Codega P, Carro M, Curiel García A, et al. EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. Nat Commun. 2017;8:2035 pubmed publisher
  7. Umaña A, Iwahori S, Kalejta R. Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol. 2018;13:189-199 pubmed publisher
  8. Paculova H, Kramara J, Simečková S, Fedr R, Soucek K, Hylse O, et al. BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors. Tumour Biol. 2017;39:1010428317727479 pubmed publisher
  9. Chong I, Aronson L, Bryant H, Gulati A, Campbell J, Elliott R, et al. Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018;67:1780-1792 pubmed publisher
  10. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  11. Ju H, Ying H, Tian T, Ling J, Fu J, Lu Y, et al. Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nat Commun. 2017;8:14437 pubmed publisher
  12. Li Z, Ivanov A, Su R, Gonzalez Pecchi V, Qi Q, Liu S, et al. The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun. 2017;8:14356 pubmed publisher
  13. Squillaro T, Antonucci I, Alessio N, Esposito A, Cipollaro M, Melone M, et al. Impact of lysosomal storage disorders on biology of mesenchymal stem cells: Evidences from in vitro silencing of glucocerebrosidase (GBA) and alpha-galactosidase A (GLA) enzymes. J Cell Physiol. 2017;232:3454-3467 pubmed publisher
  14. Liu T, Yu J, Deng M, Yin Y, Zhang H, Luo K, et al. CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. Nat Commun. 2017;8:13923 pubmed publisher
  15. Mu P, Zhang Z, Benelli M, Karthaus W, Hoover E, Chen C, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84-88 pubmed publisher
  16. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  17. Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan X, et al. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017;8:9251-9266 pubmed publisher
  18. Zimmermann M, Arachchige Don A, Donaldson M, Patriarchi T, Horne M. Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival. Cell Cycle. 2016;15:3278-3295 pubmed
  19. Ding S, Mooney N, Li B, Kelly M, Feng N, Loktev A, et al. Comparative Proteomics Reveals Strain-Specific β-TrCP Degradation via Rotavirus NSP1 Hijacking a Host Cullin-3-Rbx1 Complex. PLoS Pathog. 2016;12:e1005929 pubmed publisher
  20. Krepler C, Xiao M, Samanta M, Vultur A, Chen H, Brafford P, et al. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget. 2016;7:71211-71222 pubmed publisher
  21. Steingruber M, Kraut A, Socher E, Sticht H, Reichel A, Stamminger T, et al. Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins. Viruses. 2016;8: pubmed publisher
  22. Cao L, Zhang L, Zhao X, Zhang Y. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0161025 pubmed publisher
  23. Hoare M, Ito Y, Kang T, Weekes M, Matheson N, Patten D, et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat Cell Biol. 2016;18:979-92 pubmed publisher
  24. Hossain M, Stillman B. Opposing roles for DNA replication initiator proteins ORC1 and CDC6 in control of Cyclin E gene transcription. elife. 2016;5: pubmed publisher
  25. Nelson D, Jaber Hijazi F, Cole J, Robertson N, Pawlikowski J, Norris K, et al. Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability. Genome Biol. 2016;17:158 pubmed publisher
  26. Chen Z, Wang Z, Pang J, Yu Y, Bieerkehazhi S, Lu J, et al. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Sci Rep. 2016;6:29090 pubmed publisher
  27. Itahana Y, Zhang J, Göke J, Vardy L, Han R, Iwamoto K, et al. Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells. Sci Rep. 2016;6:28112 pubmed publisher
  28. Hong A, Tseng Y, Cowley G, Jonas O, Cheah J, Kynnap B, et al. Integrated genetic and pharmacologic interrogation of rare cancers. Nat Commun. 2016;7:11987 pubmed publisher
  29. Trapé A, Liu S, Cortés A, Ueno N, Gonzalez Angulo A. Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel. J Cancer. 2016;7:947-56 pubmed publisher
  30. Meng F, Qian J, Yue H, Li X, Xue K. SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase. Cell Cycle. 2016;15:1724-32 pubmed publisher
  31. Miyawaki S, Kawamura Y, Oiwa Y, Shimizu A, Hachiya T, Bono H, et al. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nat Commun. 2016;7:11471 pubmed publisher
  32. Strickland S, Vande Pol S. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. J Virol. 2016;90:5611-5621 pubmed publisher
  33. Nakayama R, Zhang Y, Czaplinski J, Anatone A, Sicinska E, Fletcher J, et al. Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma. Oncotarget. 2016;7:16581-92 pubmed publisher
  34. Cott C, Thuenauer R, Landi A, Kühn K, Juillot S, Imberty A, et al. Pseudomonas aeruginosa lectin LecB inhibits tissue repair processes by triggering β-catenin degradation. Biochim Biophys Acta. 2016;1863:1106-18 pubmed publisher
  35. Nassour J, Martien S, Martin N, Deruy E, Tomellini E, Malaquin N, et al. Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells. Nat Commun. 2016;7:10399 pubmed publisher
  36. Draney C, Hobson A, Grover S, Jack B, Tessem J. Cdk5r1 Overexpression Induces Primary β-Cell Proliferation. J Diabetes Res. 2016;2016:6375804 pubmed publisher
  37. Adam M, Matt S, Christian S, Hess Stumpp H, Haegebarth A, Hofmann T, et al. SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status. Cell Cycle. 2015;14:3734-47 pubmed publisher
  38. Kim Y, Chen C, Bolton E. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells. PLoS ONE. 2015;10:e0138286 pubmed publisher
  39. Kennedy A, Vallurupalli M, Chen L, Crompton B, Cowley G, Vazquez F, et al. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma. Oncotarget. 2015;6:30178-93 pubmed publisher
  40. Thoompumkal I, Subba Rao M, Kumaraswamy A, Krishnan R, Mahalingam S. GNL3L Is a Nucleo-Cytoplasmic Shuttling Protein: Role in Cell Cycle Regulation. PLoS ONE. 2015;10:e0135845 pubmed publisher
  41. Sadaie M, Dillon C, Narita M, Young A, Cairney C, Godwin L, et al. Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition. Mol Biol Cell. 2015;26:2971-85 pubmed publisher
  42. Honegger A, Schilling D, Bastian S, Sponagel J, Kuryshev V, Sultmann H, et al. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog. 2015;11:e1004712 pubmed publisher
  43. McFarlane M, MacDonald A, Stevenson A, Graham S. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). J Virol. 2015;89:5276-87 pubmed publisher
  44. VanDeusen H, Kalejta R. The retinoblastoma tumor suppressor promotes efficient human cytomegalovirus lytic replication. J Virol. 2015;89:5012-21 pubmed publisher
  45. The I, Ruijtenberg S, Bouchet B, Cristobal A, Prinsen M, van Mourik T, et al. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells. Nat Commun. 2015;6:5906 pubmed publisher
  46. Myklebust L, Van Damme P, Støve S, Dörfel M, Abboud A, Kalvik T, et al. Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects. Hum Mol Genet. 2015;24:1956-76 pubmed publisher
  47. Chipumuro E, Marco E, Christensen C, Kwiatkowski N, Zhang T, Hatheway C, et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell. 2014;159:1126-1139 pubmed publisher
  48. Gao D, Vela I, Sboner A, Iaquinta P, Karthaus W, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176-187 pubmed publisher
  49. Liao Y, Lin T, Chen C, Lin S, Au L. The antileukemia activity of natural product HQ17(3) is possibly associated with downregulation of miR-17-92 cluster. Biomed Res Int. 2014;2014:306718 pubmed publisher
  50. Negishi M, Wongpalee S, Sarkar S, Park J, Lee K, Shibata Y, et al. A new lncRNA, APTR, associates with and represses the CDKN1A/p21 promoter by recruiting polycomb proteins. PLoS ONE. 2014;9:e95216 pubmed publisher
  51. Sappino A, Buser R, Seguin Q, Fernet M, Lesne L, Gumy Pause F, et al. The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage. Oncogenesis. 2012;1:e7 pubmed publisher
  52. Burkhardt L, Fuchs S, Krohn A, Masser S, Mader M, Kluth M, et al. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. Cancer Res. 2013;73:2795-805 pubmed publisher